Crandell Keith's Form 4 filing
Aspen Neuroscience, Inc.ASPE · filed Nov 2, 2026
- Accession no.
- 0001193125-26-444147
- Filed
- Nov 2, 2026, 9:50 PM ET
- Trade date
- Nov 2, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 12 non-derivative transactions and 9 derivative transactions. Open-market purchases total $20.0M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crandell KeithCIK 0001219039 | 10% Owner |
| Nelsen RobertCIK 0001219042 | 10% Owner |
| Gillis StevenCIK 0001229592 | 10% Owner |
| Burow KristinaCIK 0001569248 | 10% Owner |
| ARCH Venture Fund X, L.P.CIK 0001757011 | 10% Owner |
| ARCH Venture Fund X Overage, L.P.CIK 0001757017 | 10% Owner |
| ARCH Venture Partners X Overage, L.P.CIK 0001768905 | 10% Owner |
| ARCH Venture Partners X, LLCCIK 0001769012 | 10% Owner |
| ARCH Venture Partners X, L.P.CIK 0001782583 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | PPurchaseAcquired | +66,666 | $15.00 | +$999,990 | 66,666 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +187,182 | –F3 | – | 253,848 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +298,258 | –F3 | – | 552,106 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +286,304 | –F3 | – | 838,410 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +295,490 | –F3 | – | 1,133,900 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +259,948 | –F3 | – | 1,393,848 | Direct | |
| Nov 2, 2026 | Common Stock | PPurchaseAcquired | +66,667 | $15.00 | +$1,000,005 | 66,667 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +298,258 | –F3 | – | 364,925 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +286,304 | –F3 | – | 651,229 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +295,490 | –F3 | – | 946,719 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionAcquired | +214,355 | –F3 | – | 1,161,074 | Direct | |
| Nov 2, 2026 | Common Stock | PPurchaseAcquired | +1,200,000 | $15.00 | +$18,000,000 | 1,200,000 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | CConversionDisposed | −187,182 | –F3 | – | 0 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionDisposed | −298,258 | –F3 | – | 0 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionDisposed | −298,258 | –F3 | – | 0 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionDisposed | −286,304 | –F3 | – | 0 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionDisposed | −286,304 | –F3 | – | 0 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionDisposed | −295,490 | –F3 | – | 0 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionDisposed | −295,490 | –F3 | – | 0 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionDisposed | −259,948 | –F3 | – | 0 | Direct | |
| Nov 2, 2026 | Common Stock | CConversionDisposed | −214,355 | –F3 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Each share of Series Seed Convertible Preferred Stock, Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock, and Series C Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted on a 1-for-9.8821 basis into shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
Referenced by the price of 9 transactions in Table I and 9 transactions in Table II.
Remarks
This Form 4 is one of two reports being filed jointly by ARCH X, AVP X LP, ARCH X Overage, AVP X Overage LP, AVP X LLC, Robert Nelsen, Steven Gillis, Keith Crandell, Kristina Burow, ARCH XIV, ARCH Venture Partners XIV, L.P., ARCH Venture Partners XIV, LLC, and Paul Berns (collectively, the "Reporting Persons").